Nivolumab in patients with previously treated metastatic squamous non-small cell lung cancer (NSCLC): results of a European single-arm, phase II trial (CHECKMATE 171) including patients aged >= 70 years or with poor performance status.
Authors
Popat, SArdizzoni, A
Ciuleanu, T
Dols, M
Laktionov, K
Szilasi, M
Califano, Raffaele
Costa, E
Griffiths, R
Paz-Ares, L
Szczylik, C
Jaime, J
Isla, D
Jassem, J
Appel, W
Van Meerbeeck, J
Woolf, J
Jiang, J
Molife, L
Felip, E
Affiliation
Medical Oncology, Royal Marsden Hospital, SW3 6JJ - LondonIssue Date
2017